Assessment of Parkinson disease quality measures on 12-month patient outcomes

Conclusions We found no clinically important improvement in patient outcomes with higher adherence levels. It is important that QM developers validate QMs to ensure that they fulfill the intended goal of improved patient outcomes.

http://cp.neurology.org/cgi/content/short/10/1/58?rss=1

Source: Neurology Clinical Practice - February 9, 2020 Category: Neurology Authors: Martello, J., Shulman, L. M., Barr, E., Gruber-Baldini, A., Armstrong, M. J. Tags: Outcome research, Quality of life, Parkinson's disease/Parkinsonism Source Type: research